Protected and Unprotected Radiation Exposure to the Eye Lens During Endovascular Procedures in Hybrid Operating Rooms.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
11 2022
Historique:
received: 04 08 2021
revised: 22 04 2022
accepted: 19 06 2022
pubmed: 28 6 2022
medline: 2 12 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

Radiation cataract has been observed at lower doses than previously thought, therefore the annual limit for equivalent dose to the eye lens has been reduced from 150 to 20 mSv. This study evaluated radiation exposure to the eye lens of operators working in a hybrid operating room before and after implementation of a dose reduction program. From April to October 2019, radiation exposure to the first operator was measured during all consecutive endovascular procedures performed in the hybrid operating room using BeOSL H A total of 181 consecutive patients underwent an endovascular procedure in the hybrid operating room. The median unprotected eye lens dose (outside lead glasses) of the main operator was 0.049 mSv for endovascular aortic repair (EVAR) (n = 30), 0.042 mSv for thoracic endovascular aortic repair (TEVAR) (n = 23), 0.175 mSv for complex aortic fenestrated or branched endovascular procedures (F/BEVAR; n = 15), and 0.042 mSv for peripheral interventions (n = 80). Compared with the control period, EVAR had 75% lower, TEVAR 79% lower, and F/BEVAR 55% lower radiation exposure to the unprotected eye lens of the first operator. The lead glasses led to a median reduction in the exposure to the eye lens by a factor of 3.4. The implementation of a dose reduction program led to a relevant reduction in radiation exposure to the head and eye lens of the first operator in endovascular procedures. With optimum radiation protection measures, including a ceiling mounted shield and lead glasses, more than 440 EVARs, 280 TEVARs, or 128 FEVARs could be performed per year before the dose limit for the eye lens of 20 mSv was reached.

Identifiants

pubmed: 35760276
pii: S1078-5884(22)00401-4
doi: 10.1016/j.ejvs.2022.06.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

567-572

Informations de copyright

Copyright © 2022 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Auteurs

Silvan Jungi (S)

Department of Vascular and Endovascular Surgery, University Hospital of Heidelberg, Heidelberg, Germany; Department of Vascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Marius Ante (M)

Department of Vascular and Endovascular Surgery, University Hospital of Heidelberg, Heidelberg, Germany.

Philipp Geisbüsch (P)

Department of Vascular and Endovascular Surgery, University Hospital of Heidelberg, Heidelberg, Germany.

Herbert Hoedlmoser (H)

Mirion Technologies (AWST) GmbH, Munich, Germany.

Philip Kleinau (P)

Mirion Technologies (AWST) GmbH, Munich, Germany.

Dittmar Böckler (D)

Department of Vascular and Endovascular Surgery, University Hospital of Heidelberg, Heidelberg, Germany. Electronic address: dittmar.boeckler@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH